Research Continuity During COVID-19
Watch this webinar for tips on how to ensure research continuity during COVID-19 by running your trial with…
Common shortcomings of clinical research data for PMCF
The following is an excerpt from our free whitepaper ‘Satisfying PMCF requirements by utilizing IIS data’. Click here…
Guide to eConsent Readiness in the US, Europe, and Israel
eConsent regulations vary widely across the world. Download this guide for an overview of the current regulatory situation in nine countries.
eConsent – The Enrollment Solution for Decentralized Trials
Join this webinar to understand how eConsent works, where it falls in the regulatory guidelines & see a practical demonstration of eConsent software.
Castor Announces Partnership With Click Therapeutics to Support Decentralized Clinical Trials
Hoboken, New Jersey: September 2, 2020: Castor, a leading provider of clinical trial technology that automates the research…
Castor Raises a $12M Series A to Further Their Support for COVID-19 Research
With 4,000 live studies and 2M enrolled patients across 90 countries, Castor will use the funding to further…
An Expert Panel on Decentralized and Hybrid Trials, Pre and Post COVID-19
The world may have changed seemingly overnight, but clinical research and medical innovation must continue now more than…
What Will Trial Enrollment & Engagement Look Like in a Socially-Distanced World?
When the COVID-19 pandemic began, the industry needed to focus immediately on research continuity and determine how to mitigate the impact on clinical trials while protecting participant safety.
Using Decentralized Trial Technology to Ensure Study Continuity and Data Quality During COVID-19 and Beyond
Download this white paper to learn why patient-centric, remote research technologies such as eConsent, EDC, and ePRO are critical during COVID-19 and beyond.